NIH Highlighted Topic: Advancing the Science of Prenatal Dietary Supplements
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The National Institutes of Health (NIH) is encouraging innovative research proposals focused on advancing the science of prenatal dietary supplements to improve maternal health, fetal development, and long-term child health outcomes. This highlighted topic supports multidisciplinary projects designed to generate pregnancy-specific evidence for nutrient requirements, biomarker development, supplement formulation, bioavailability, and maternal-child health optimization across pregnancy and early life.
NIH recognizes that many pregnant women experience nutrient deficiencies while others may exceed safe nutrient levels due to inconsistent prenatal supplement formulations and limited pregnancy-specific evidence. The initiative is particularly interested in projects that modernize prenatal nutrition science through biomarker innovation, metabolomics, computational modeling, clinical nutrition studies, and translational supplement formulation research.
Companies developing prenatal nutrition technologies, AI-enabled nutrition analytics platforms, biomarker discovery systems, supplement formulation technologies, metabolomics tools, maternal-fetal monitoring systems, microbiome analytics platforms, or precision nutrition solutions may be strong candidates for funding.
Areas of interest include pregnancy-specific nutrient metabolism, micronutrient biomarkers, nutrient bioavailability, dietary supplement formulation science, maternal-child outcomes, fetal neurodevelopment, placental biology, prenatal exposure analytics, environmental interaction modeling, microbiome effects, and maternal cardiometabolic health. NIH is also encouraging projects leveraging stable isotope methods, multi-omics technologies, adaptive clinical trials, in vitro bioaccessibility models, and longitudinal maternal-child cohort data to improve prenatal nutrition recommendations and supplement safety.
Funding is available through the NIH SBIR/STTR Program, which currently provides up to approximately $323,090 for Phase I projects and up to $2,153,927 for Phase II projects, with opportunities for additional commercialization and follow-on funding depending on project scope and translational impact.
This highlighted topic is supported by multiple NIH Institutes and Offices including ODS, NIAAA, NIDCR, NIEHS, OBSSR, ODP, ONR, and ORWH, all of which are seeking transformative innovations that improve prenatal nutrition science, maternal-child health, fetal development, precision supplementation, and long-term health outcomes across the lifespan.
How much funding would I receive?
Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.
What could I use the funding for?
Funding may support the research, development, validation, and commercialization of prenatal nutrition technologies, biomarker systems, supplement formulation platforms, maternal-fetal analytics tools, and precision nutrition solutions.
Eligible activities may include:
AI and machine learning platforms for prenatal nutrition analytics and risk prediction
Biomarker discovery and metabolomics technologies for pregnancy-specific nutrient assessment
Prenatal dietary supplement formulation and bioavailability testing systems
Stable isotope and nutrient metabolism research technologies
Maternal-fetal monitoring and longitudinal health analytics platforms
Precision nutrition and personalized prenatal supplementation systems
In vitro bioaccessibility and nutrient absorption modeling technologies
Multi-omics, microbiome, and maternal-fetal systems biology platforms
Environmental exposure and nutrient interaction analytics systems
Clinical nutrition trial infrastructure and adaptive study platforms
Prenatal supplement stability, dissolution, and degradation testing technologies
Alternative supplement delivery systems including encapsulation, emulsions, powders, and liquid formulations
Neurodevelopmental, placental, immune, and cardiometabolic outcome monitoring technologies
Fetal alcohol spectrum disorder (FASD) nutrition intervention platforms
Craniofacial, dental, and skeletal development nutrition research technologies
Real-world evidence and maternal-child cohort data integration systems
Prototype development, translational studies, and clinical validation research
Commercialization planning, regulatory preparation, and manufacturing scale-up activities
Funding may also support personnel, laboratory testing, software engineering, cloud infrastructure, AI model development, bioinformatics analysis, clinical nutrition research, analytical chemistry, toxicology testing, supplement formulation development, intellectual property protection, regulatory strategy, and commercialization activities necessary to advance a scalable and commercially viable maternal health or nutrition science solution aligned with NIH priorities.
Are there any additional benefits I would receive?
Beyond the formal funding award, awardees gain several strategic advantages:
Government Validation and Credibility:
Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.Enhanced Visibility and Market Recognition:
Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities.Access to the Federal Innovation Ecosystem:
Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.Stronger Commercial and Exit Potential:
By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment.
What is the timeline to apply and when would I receive funding?
Applications are accepted each year on January 5th, April 5th, and September 5th. Funding is received approximately 9 months after submission.
Where does this funding come from?
Funding comes from the U.S. Department of Health and Human Services, with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.2% for SBIR, 0.45% for STTR) to support small business innovation.
Who is eligible to apply?
Applicants must be U.S. small business concerns (SBCs) that:
Are organized for profit with a U.S. place of business.
Have ≤ 500 employees including affiliates.
Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.
What companies and projects are likely to win?
Projects that demonstrate:
A clear unmet medical or public-health need,
Strong scientific rationale and feasibility,
High commercialization potential, supported by a realistic market and regulatory strategy, and
Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).
Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption.
Are there any restrictions I should know about?
Companies must complete multiple federal registrations (SAM.gov, Grants.gov, eRA Commons, SBA Company Registry) before applying.
Foreign entities are not eligible.
Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation.
How long will it take me to prepare an application?
For a first-time applicant, preparing a competitive submission will likely take 120–200 hours in total.
How can BW&CO help?
Our team specializes in complex federal R&D proposals and can:
Triple your likelihood of success through proven strategy and insider-aligned proposal development
Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations
Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.
